1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Gutiérrez C, Hernández-Novoa B, Pérez-Elías MJ, Moreno AM, Holguín A, Dronda F, Casado JL, Moreno S.

    Prevalence of primary resistance mutations to integrase inhibitors in treatment-naïve and -experienced patients infected with B and non-B HIV-1 variants.

    HIV CLINICAL TRIALS . 14(1): 10-16.

    [doi:10.1310/hct1401-10]

  • May MT, Hogg RS, Justice AC, Shepherd BE, Costagliola D, Ledergerber B, Thiébaut R, Gill MJ, Kirk O, van Sighem A, Saag MS, Navarro G, Sobrino-Vegas P, Lampe F, Ingle S, Guest JL, Crane HM, D'Arminio Monforte A, Vehreschild JJ, Sterne JA.

    Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics

    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY . 41(6): 1807-1820. Nº de citas: 31

    [doi:10.1093/ije/dys164]

  • Len O, Rodríguez-Pardo D, Gavaldà J, Aguado JM, Blanes M, Borrell N, Bou G, Carratalà J, Cisneros JM, Fortún J, Gurguí M, Montejo M, Cervera C, Muñoz P, Asensio A, Torre-Cisneros J, Pahissa A.

    Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: a prospective and multicentre cohort study

    TRANSPLANT INTERNATIONAL . 25(12): 1275-1281. Nº de citas: 32

    [doi:10.1111/j.1432-2277.2012.01568.x]

  • Vidal E, Torre-Cisneros J, Blanes M, Montejo M, Cervera C, Aguado JM, Len O, Carratalá J, Cordero E, Bou G, Muñoz P, Ramos A, Gurguí M, Borrell N, Fortún J.

    Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort

    TRANSPLANT INFECTIOUS DISEASE . 14(6): 595-603. Nº de citas: 98

    [doi:10.1111/j.1399-3062.2012.00744.x]

  • Podzamczer D, Martínez E, Domingo P, Ferrer E, Viciana P, Curto J, Pérez-Elías MJ, Ocampo A, Santos I, Knobel H, Estrada V, Negredo E, Segura F, Portilla J, Ribera E, Galindo J, Antela A, Carmena J, Castaño M.

    Switching to Raltegravir in Virologically Suppressed in HIV-1-Infected Patients: A Retrospective, Multicenter, Descriptive Study

    CURRENT HIV RESEARCH . 10(8): 673-678. Nº de citas: 3

    [doi:10.2174/157016212803901428]

  • Martínez E, D'Albuquerque PM, Llibre JM, Gutierrez F, Podzamczer D, Antela A, Berenguer J, Domingo P, Moreno X, Perez I, Pich J, Gatell JM, SPIRAL Trial Group.

    Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir

    AIDS . 26(18): 2315-2326. Nº de citas: 99

    [doi:10.1097/QAD.0b013e328359f29c]

  • Wikman-Jorgensen PE, Henríquez-Camacho CA, Serrano-Villar S, Pérez-Molina JA.

    The role of artesunate for the treatment of urinary schistosomiasis in schoolchildren: a systematic review and meta-analysis

    PATHOGENS AND GLOBAL HEALTH . 106(7): 397-404. Nº de citas: 3

    [doi:10.1179/2047773212Y.0000000038]

  • Monge S, Guillot V, Alvarez M, Peña A, Viciana P, García-Bujalance S, Pérez Elias MJ, Iribarren JA, Gutiérrez F, Itziar Casado M, Garcia F.

    Analysis of transmitted drug resistance in Spain in the years 2007-2010 documents a decline in mutations to the non-nucleoside drug class

    CLINICAL MICROBIOLOGY AND INFECTION . 18(11): 485-490. Nº de citas: 24

    [doi:10.1111/1469-0691.12011]

  • Theys K, Deforche K, Vercauteren J, Libin P, van de Vijver DA, Albert J, Asjö B, Balotta C, Bruckova M, Camacho RJ, Clotet B, Coughlan S, Grossman Z, Hamouda O, Horban A, Korn K, Kostrikis LG, Kücherer C, Nielsen C, Paraskevis D, Poljak M, Puchhammer-Stockl E, Riva C, Ruiz L, Liitsola K, Schmit JC, Schuurman R, Sönnerborg A, Stanekova D, Stanojevic M, Struck D, Van Laethem K, Wensing AM, Boucher CA, Vandamme AM, SPREAD-programme.

    Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

    Retrovirology . 9: 81-81. Nº de citas: 22

    [doi:10.1186/1742-4690-9-81]

  • Hernando V, Perez-Cachafeiro S, Lewden C, Gonzalez J, Segura F, Oteo JA, Rubio R, Dalmau D, Moreno S, Amo JD.

    All-cause and liver-related mortality in HIV positive subjects compared to the general population: Differences by HCV co-infection

    JOURNAL OF HEPATOLOGY . 57(4): 743-751. Nº de citas: 86

    [doi:10.1016/j.jhep.2012.06.010]

  • Vallejo A, Gutierrez C, Hernandez-Novoa B, Diaz L, Madrid N, Abad-Fernandez M, Dronda F, Perez-Elias MJ, Zamora J, Muñoz E, Muñoz-Fernandez MA, Moreno S.

    The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients

    AIDS . 26(15): 1885-1894. Nº de citas: 62

    [doi:10.1097/QAD.0b013e3283584521]

  • Askling HH, Bruneel F, Burchard G, Castelli F, Chiodini PL, Grobusch MP, Lopez-Vélez R, Paul M, Petersen E, Popescu C, Ramharter M, Schlagenhauf P.

    Management of imported malaria in Europe

    MALARIA JOURNAL . 11: 328-328. Nº de citas: 93

    [doi:10.1186/1475-2875-11-328]

  • Hernando V, Sobrino-Vegas P, Burriel MC, Berenguer J, Navarro G, Santos I, Reparaz J, Martínez MA, Antela A, Gutiérrez F, del Amo J.

    Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms

    AIDS . 26(14): 1829-1834. Nº de citas: 23

    [doi:10.1097/QAD.0b013e328352ada4]

  • Colubi MM, Pérez-Elías MJ, Elías L, Pumares M, Muriel A, Zamora AM, Casado JL, Dronda F, López D, Moreno S.

    Missing Scheduled Visits in the Outpatient Clinic as a Marker of Short-Term Admissions and Death

    HIV CLINICAL TRIALS . 13(5): 289-295. Nº de citas: 23

    [doi:10.1310/hct1305-289]

  • del Palacio M, Romero S, Casado JL.

    The Use of Biomarkers for Assessing HAART-Associated Renal Toxicity in HIV-Infected Patients

    CURRENT HIV RESEARCH . 10(6): 521-531. Nº de citas: 9

    [doi:10.2174/157016212802429802]

  • Podzamczer D, Tiraboschi JM, Mallolas J, Curto J, Cárdenes MA, Casas E, Castro A, Echevarría S, Leal M, Lopez Bernaldo de Quirós JC, Moreno S, Puig T, Ribera E, Villalonga C, Gómez-Sirvent JL, García-Henarejos JA, Lopez-Aldeguer J, Barrufet P, Force L, Santos I, Sanz J.

    Long-Term Benefits of Nevirapine-Containing Regimens: Multicenter Study with 506 Patients, Followed-Up a Median of 9 Years

    CURRENT HIV RESEARCH . 10(6): 513-520. Nº de citas: 5

    [doi:10.2174/157016212802429820]

  • Berenguer J, Rodríguez E, Miralles P, Von Wichmann MA, López-Aldeguer J, Mallolas J, Galindo MJ, Van Den Eynde E, Téllez MJ, Quereda C, Jou A, Sanz J, Barros C, Santos I, Pulido F, Guardiola JM, Ortega E, Rubio R, Jusdado JJ, Montes ML, Gaspar G, Esteban H, Bellón JM, González-García J.

    Sustained Virological Response to Interferon Plus Ribavirin Reduces Non-Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus

    CLINICAL INFECTIOUS DISEASES . 55(5): 728-736. Nº de citas: 129

    [doi:10.1093/cid/cis500]

  • Flores-Chavez M, Cruz I, Nieto J, Gárate T, Navarro M, Pérez-Ayala A, López-Vélez R, Cañavate C.

    Sensitivity and Specificity of an Operon Immunochromatographic Test in Serum and Whole-Blood Samples for the Diagnosis of Trypanosoma cruzi Infection in Spain, an Area of Nonendemicity

    CLINICAL AND VACCINE IMMUNOLOGY . 19(9): 1353-1359. Nº de citas: 10

    [doi:10.1128/CVI.00227-12]